Prospeo
Hero Section BackgroundHero Section Background
HanchorBio 漢康生技股份有限公司

HanchorBio 漢康生技股份有限公司 Email Formats

Biotechnology ResearchFlag of TWZhongshan District, Taipei City, Taiwan, Province of China21-50 Employees

HanchorBio 漢康生技股份有限公司 Email Formats

HanchorBio 漢康生技股份有限公司 uses 2 email formats. The most common is {first name}_{last name} (e.g., john_doe@hanchorbio.com), used 63.6% of the time.

FormatExamplePercentage
{first name}_{last name}
john_doe@hanchorbio.com
63.6%
{first initial}_{last name}
j_doe@hanchorbio.com
36.4%

Key Contacts at HanchorBio 漢康生技股份有限公司

Flag of CN

Henry Ye

Associate Bd Director

Flag of TW

Tsaikuei Shen

Associate Director ,Biologics

Flag of TW

Vivian Meng-Wei Kuo

Cmc Senior Director

Flag of TW

鴻梵 Hongfan Wang

Associate Director Of Project Management

Flag of TW

沛倫 蔡

Associate Director, Analytical Method Development

Flag of TW

Aric Wang

Head Of Translational Medicine. Associate Director.

Flag of TW

I-Yin Chen

Director

Company overview

Headquarters5F-1, No.1, Sec. 1, Tiding Blvd.,, Taipei, Neihu District 114, TW
Phone number+886227921366
Website
NAICS541714
Keywords
Immunotherapy And Fc-Fusion Protein
Founded2020
Employees21-50
Socials

About HanchorBio 漢康生技股份有限公司

HanchorBio (漢康生技) is developing a technology for the creation of next generation personalized biotherapeutics. Based in San Francisco, Taipei, and Shanghai, we are led by a group of pharmaceutical industry veterans with proven track-record of success is biologics discovery and global development with bold vision to rewrite immunotherapies. Committed to reactivating the immune system to fight against diseases, our proprietary Fc-based designer biologics (FBDB™) platform enables unique biologics with diverse multi-targeting modalities to unleash both innate and adaptive immunity to help revolutionize the treatment of people with cancer and other debilitating diseases. Our FBDB™ platform has successfully delivered proof-of-concept data in several in-vivo animal models. By making breakthroughs in multi-functional innovative molecular configurations in R&D and improving the manufacturing methodology in CMC, we develop transformative medicines to address unmet medical needs.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry
Director
C-Suite

Employees by Department

HanchorBio 漢康生技股份有限公司 has 10 employees across 5 departments.

Departments

Number of employees

Funding Data

Explore HanchorBio 漢康生技股份有限公司's funding history, including investment rounds, total capital raised, and key backers.

Funding Date
Round
Amount
Link to Article
2022-09-254$20,000,000

Funding Insights

$20,000,000

Total funding amount

$20,000,000

Most recent funding amount

1

Number of funding rounds

HanchorBio 漢康生技股份有限公司 Tech Stack

Discover the technologies and tools that power HanchorBio 漢康生技股份有限公司's digital infrastructure, from frameworks to analytics platforms.

PWA

PWA

Miscellaneous

Swiper

Swiper

JavaScript libraries

jQuery UI

jQuery UI

JavaScript libraries

Google Maps

Google Maps

Maps

Microsoft 365

Microsoft 365

Email

Cloudflare

Cloudflare

CDN

jQuery

jQuery

JavaScript libraries

HTTP/3

HTTP/3

Miscellaneous

PHP

PHP

Programming languages

Google Analytics

Google Analytics

Analytics

YouTube

YouTube

Video players

Bootstrap

Bootstrap

UI frameworks

Frequently asked questions

HanchorBio 漢康生技股份有限公司 is located in Zhongshan District, Taipei City, TW.
You can reach HanchorBio 漢康生技股份有限公司 at +886227921366.
HanchorBio 漢康生技股份有限公司 was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.
HanchorBio 漢康生技股份有限公司 has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.
HanchorBio 漢康生技股份有限公司 has raised a total of $20,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles